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Abstract 
 
Caspase recruitment domain family member 18 (CARD18, Iceberg) is known as a negative 
regulatory molecule that inhibits inflammatory events by terminating inflammasome 
activation due to a direct interaction with pro-caspase-1. 
During the investigation of molecular mechanisms in keratinocytes that contribute to the 
pathogenesis of psoriasis, we found that CARD18 expression differs in healthy and psoriatic 
skin; moreover, CARD18 demonstrated altered response under inflammatory conditions in 
healthy and psoriatic skin. In healthy skin, low basal CARD18 expression was detected, 
which showed significant elevation in response to inflammatory stimuli (lymphokine 
treatment or mechanical injury). In contrast, higher basal expression was observed in psoriatic 
non-involved skin, but no further induction could be detected. 
We demonstrated that keratinocytes express CARD18 both at mRNA and protein levels and 
the expression increased in parallel with differentiation. The investigation of cellular 
inflammatory processes revealed that psoriasis-associated danger signals triggered the 
expression of inflammasome components (AIM2, Caspase-1) and CARD18 as well as IL-1β 
production of keratinocytes. Furthermore, gene-specific silencing of CARD18 in cells treated 
with cytosolic DNA (poly(dA:dT)) resulted in increased IL-1β secretion, suggesting a 
negative regulatory role for CARD18 in keratinocyte inflammatory signaling. 
The differential regulation of CARD18 in healthy and psoriatic uninvolved epidermis may 
contribute to the susceptibility of psoriasis. Furthermore, our in vitro results indicate that 
CARD18 may contribute to the fine tuning of keratinocyte innate immune processes. 
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1. Introduction 
The innate immune system constitutes the first line of defense that detects pathogen- and 
damage-associated molecular patterns. Inflammation is a protective physiological response; 
however, impaired activation and/or down-regulation of inflammatory signaling may result in 
inflammatory diseases, some of which involve multiple organs. Inflammasomes, located in 
the cytosol, are part of the innate immune system. These multi-molecular complexes are 
responsible for the recognition of various cytoplasmic danger signals and provoke 
inflammatory responses by recruiting and activating pro-caspase-1 through autocatalytic 
cleavage (Schroder and Tschopp, 2010). The activation of caspase-1 ultimately leads to the 
processing and, thus, secretion of pro-inflammatory cytokines, most importantly interleukin 
(IL) 1β and IL-18, and also induces pyroptotic cell death (Bauernfeind et al., 2011). IL-1β 
affects nearly all cell types and is fundamental for innate as well as adaptive immunity 
(Dinarello, 1996). Increased IL-1β abundance plays an important role in a number of chronic 
and acute inflammatory diseases (Li et al., 2008), such as psoriasis. 
Psoriasis is a life-long skin disease with chronic inflammatory and immune-mediated 
characteristics, affecting approximately 2% of the population (Christophers, 2001). The 
disease usually manifests as raised, erythematous oval plaques on the skin (Nestle et al., 2009 
a). In addition to decreasing the quality of life, psoriasis is also associated with a high degree 
of co-morbidities, including arthritis, atherosclerosis, inflammatory bowel disease, obesity, 
type 2 diabetes and depression. The clinical phenotype of these co-morbidities illustrates the 
importance of the dysfunctional immune system (Rivas Bejarano and Valdecantos, 2013). 
The importance of innate immune dysregulation in psoriasis has long been recognized (Bos et 
al., 2005; Nickoloff, 1999; Nickoloff et al., 2000). The activated state of the innate immune 
system is represented by the activity of natural killer cells, dendritic cells, neutrophils and 
keratinocytes, and an increased expression of cytokines (Iversen and Johansen, 2008). Pro-
inflammatory cytokines, such as IL-1β and IL-18, have been shown to play an important role 
in the pathogenesis of psoriasis, i.e., initiating and mediating the infiltration of immune cells 
and stimulating keratinocytes to proliferate (Johansen et al., 2007; Mee et al., 2007; Nestle et 
al., 2009 b). Elevated IL-1β and IL-18 expression has been observed in inflamed skin; 
moreover, the increased IL-1β is produced mostly by keratinocytes (Koizumi et al., 2001; 
Renne et al., 2010). Certain cytokines, inflammasomes and inflammatory caspases, such as 
caspase-1, have been described as potential inducers and regulators of skin inflammation in 
contact hypersensitivity and in psoriasis (Iversen and Johansen, 2008; Salskov-Iversen et al., 
2011). 
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Cytosolic DNA is a potent inducer of the innate immune response and has been proposed to 
be involved in the pathogenesis of psoriasis (Dombrowski et al., 2011; Lande et al., 2007; 
Nestle et al., 2009 a). The DNA-sensor-containing absence in melanoma 2 (AIM2) 
inflammasome is triggered by both self-derived and pathogen-released (Francisella 
tularensis, L. monocytogenes, vaccinia virus) cytosolic double-stranded DNA (Fernandes-
Alnemri et al., 2009; Rathinam and Fitzgerald, 2010). Recently, abundant cytosolic DNA and 
increased AIM2 expression were found to be present in keratinocytes in psoriatic lesions but 
not in healthy skin (Dombrowski et al., 2011), and have been suggested to contribute to the 
abnormal IL-1β secretion in psoriasis. Keratinocytes express four different 
deoxyribonucleases (DNases), which remove extracellular DNA by degradation. In psoriatic 
skin, three of these DNases do not exhibit DNase activity and one seems to have reduced 
DNA-affinity. The optimum pH of these DNA-binding proteins likely changes during 
keratinization (Reimer et al., 1978), resulting in aberrant DNase activity and the presence of 
excess DNA fragments in the cytosol. 
Our recent large-scale gene expression study has revealed that the caspase recruitment domain 
family member 18 (CARD18, Iceberg) transcript is differentially expressed in psoriatic non-
involved epidermis compared to healthy epidermis (Szabó et al., 2014). CARD18, a member 
of CARD-only protein (COP) family, has only one CARD domain which exhibits sequence 
similarity to the CARD prodomain of caspase-1. COP family members probably arose 
through gene duplication and are restricted to the higher primates (Kersse et al., 2007). 
CARD18 serves as a decoy protein which can modify the activity of inflammasome by 
inhibiting the generation of active IL-1β and IL-18 through direct interaction with pro-
caspase-1 (Druilhe et al., 2001; Humke et al., 2000). Further investigation of the molecular 
biology and functions of CARD18 should shed light on yet unknown basic innate immune 
mechanisms and could lead to the identification of possible therapeutic target(s). Therefore, 
we investigated CARD18 expression in cultured keratinocytes exposed to various psoriasis-
related stress factors and sentinels in psoriasis. We also addressed whether CARD18 
contributes to AIM2 inflammasome-mediated keratinocyte functions, and if this small 
molecule could modify inflammatory processes in keratinocytes. 
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2. Materials and methods 
 
2.1. Patients 
Shave biopsy samples for organotypic skin cultures were taken from the non-involved buttock 
area of five young male psoriasis patients and five age- and gender-matched healthy controls. 
Subsequently, organotypic skin cultures were established, as has been described previously 
(Szabó et al., 2014). 
For immunohistochemical staining, patients with moderate-to-severe psoriasis vulgaris (n=2) 
and healthy (n=2) volunteers were enrolled in the study.  
In another set of experiments, the skin of psoriatic patients (n=2) and healthy volunteers (n=2) 
were subjected to tape stripping (TS). Punch biopsies were taken from the area once before 
and twice after (24 and 48 hours) the treatment. 
Written informed consent was obtained from all donors involved in the study. Psoriatic 
patients had not undergone treatment for 4 weeks before sampling. The study was approved 
by the Human Investigation Review Board of the University of Szeged, complying with the 
ethical standards of research and in accordance with the Helsinki Declaration. 
 
2.2. Cell cultures 
Normal human epidermal keratinocytes (NHEKs) were separated from skin specimens 
obtained from the Plastic Surgery Unit of our department. The epidermis and the dermis were 
separated by overnight incubation in Dispase (Roche Diagnostics, Manheim, Germany), and 
keratinocytes were obtained after maceration in 0.25% trypsin. Cells were grown in 
75 cm
2
 cell culture flasks and were maintained in keratinocyte serum-free medium (Gibco 
Keratinocyte SFM Kit; Life Technologies, Copenhagen, Denmark), supplemented with 1% 
antibiotic/antimycotic solution (PAA Laboratories GmBH, Pasching, Austria) and 1% L-
glutamine (PAA Laboratories) at 37 °C in a humidified atmosphere with 5% CO2. The 
calcium concentration of the medium was <0.1 mM. The medium was changed every 2 days. 
Third passage keratinocytes were used for experiments. 
A previously described, an in vitro keratinocyte-differentiating model was used (Pivarcsi et 
al., 2001). For the induction of AIM2 inflammasome, cells were subjected to 5 ng/ml tumor 
necrosis factor (TNF) α (R&D Systems, Minneapolis, MN, USA) and 5 ng/ml interferon 
(IFN) ɣ (R&D Systems) pretreatment and 1 μg/ml polydeoxyadenylic acid–
polydeoxythymidylic acid double-stranded homopolymer (poly(dA:dT)), Sigma Aldrich, 
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Saint Louis, MO, USA) transfection. The supernatants were collected and cells were 
harvested at the indicated time points after treatments. 
 
2.3. Real-time RT-PCR 
Total RNA was isolated from cells using TRIzol
®
 Reagent (Invitrogen Corp., Carlsbad, CA, 
USA), following the manufacturer’s instructions. cDNA was synthesized from 1 µg total 
RNA with the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA). Real-
time RT-PCR experiments were carried out with the Universal Probe Library system (F. 
Hoffmann-La Roche AG, Basel, Switzerland). The following primers were used: CARD18 
forward AAGACCCCTCAACTTGCCTCA and reverse CTCCCTTGGAAGAAGCTCTG, 
(UPL probe number 50); AIM2 forward AGTCCTCTGCTAGTTAAGCTCTCTG and reverse 
TCTGACAACTTTGGGATCAGC (UPL probe number 87); and caspase-1 forward 
CCTTAATATGCAAGACTCTCAAGGA and reverse TAGCTGGGTTGTCCTGCACT 
(UPL probe number 17). PCR assays were performed with the C1000 Touch Thermal Cycler 
(Bio-Rad Laboratories). The expression of each gene was normalized to the 18S ribosomal 
RNA gene. Relative mRNA levels were calculated by the ΔΔCt method. Data from different 
treatments were compared using one-tailed t test. Differences were considered significant 
when P≤0.05. 
 
2.4. Immunohistochemistry 
Paraffin-embedded specimens from healthy, involved and non-involved psoriatic skin were 
obtained for CARD18 immunohistochemistry (IHC). Samples were fixed in 4% buffered 
formaldehyde for 24 h. The tissue block was subjected to paraffin embedding and 4-μm-thick 
sections were placed on silanized slides, dewaxed in xylene for 3 x 5 min and rehydrated in 
decreasing concentrations of ethanol. Tissue retrieval was performed in citrate buffer (10 mM, 
pH 6.0). For nonspecific antigen blocking, 1% horse serum containing 0.5% BSA-TBS was 
used for 30 min. Sections were incubated with anti-CARD18 goat polyclonal IgG antibody 
(Santa Cruz Biotechnology, Dallas, TX, USA; 1:300) at 4°C overnight. The anti-CARD18 
goat polyclonal antibody was not included in the staining procedure when sections were 
stained for the matching negative controls. After three washing steps with phosphate-buffered 
saline (PBS), biotinylated anti-goat IgG (1:200, Vector Laboratories Inc., Burlingame, CA, 
USA) was applied for 30 min at room temperature. After one PBS wash, sections were 
incubated in ExtrAvidin peroxidase (1:400, Sigma Aldrich) for 30 min at room temperature. 
Visualization was performed by adding AEC reagent (0.05% 3-amino-9-ethylcarbazole 
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dissolved in N,N-dimethylformamide, 0.01% H2O2, and 0.05 M acetate buffer). Sections were 
counterstained with hematoxylin for 10 seconds and subsequently analyzed with a Zeiss Axio 
Imager fluorescent light microscope (Carl Zeiss MicroImaging, Thornwood, NY, USA) fitted 
with a Carl Zeiss AxioCamMRc camera. 
 
2.5. Immunofluorescence staining 
NHEK cells were trypsinized, harvested by centrifugation and resuspended in PBS before 10
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cells were centrifuged onto a slide using a cytocentrifuge (Cytopro™, Wescor, Logan, UT, 
USA) and dried overnight at room temperature. The slides were fixed in 2% 
paraformaldehyde for 20 min at room temperature. Nonspecific antigens were blocked for 
30 min at room temperature in 1% donkey serum containing 0.5% BSA-TBS. Slides were 
incubated overnight at 4
o
C with anti-CARD18 goat polyclonal IgG antibody (Santa Cruz 
Biotechnology; 1:250) in 0.5% BSA-TBS. Anti-goat Alexa Fluor 546 donkey secondary 
antibody solutions (Sigma Aldrich) were applied for 1 hour at room temperature. Cell nuclei 
were counterstained with 4,6-diamidino-2-phenylindole (DAPI, Sigma Aldrich, 1:100) and 
mounted with Fluoromount-G (Southern Biotech, Birmingham, AL, USA). Pictures were 
taken with the aid of a Zeiss Axio Imager fluorescent light microscope (Carl Zeiss 
MicroImaging) fitted with a Carl Zeiss AxioCamMRc 5 camera. 
 
2.6. ELISA 
Cell supernatants were centrifuged (5000 rpm, 4 min, 4°C) to pellet cell debris and the 
amount of IL-1β was determined by ELISA (Human IL-1β ELISA Duo Set, R&D Systems), 
according to the manufacturer's instructions. 
 
2.7. Gene specific silencing 
Gene-specific silencing was performed with an siRNA transfection method. NHEK cells were 
transiently transfected at approximately 70% confluency using the X-tremeGENE siRNA 
Transfection Reagent (Roche), according to the manufacturer's instructions. For gene-specific 
silencing of CARD18, siRNA duplex was applied: ICEBERG siRNA (h), sc-105550, and 
control siRNA-A, sc-37007 (Santa Cruz Biotechnology). The most effective CARD18 
silencing was achieved in serum-free culture medium without additive and supplements. The 
effectiveness of the silencing was measured by real-time RT-PCR (Supplementary Fig. 1.). 
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3. Results 
 
3.1. CARD18 gene expression differs in healthy and psoriatic non-involved epidermis upon 
T-cell lymphokine treatment 
There is evidence that psoriatic non-involved epidermal keratinocytes carry molecular and 
cellular alterations that contribute to the occurrence of psoriatic symptoms. We have recently 
reported the results of a cDNA microarray experiments in which 61 annotated genes were 
differentially expressed in psoriatic non-involved and healthy epidermis upon T-cell 
lymphokine treatment (Szabó et al., 2014). In this experiment, organotypic skin cultures were 
treated with a cytokine mixture (GM-CSF, IL-3, IFN-ɣ) that has been shown to mimic the 
effect of psoriatic T-cell lymphokines (Bata-Csorgo et al., 1995). CARD18, identified as a 
differentially expressed gene in our experiment, encodes a protein that belongs to the COP 
family. CARD18 is a negative regulator of IL-1β maturation, inhibiting inflammasome 
activation directly by interacting with pro-caspase-1 (Bauernfeind et al., 2011). To validate 
the cDNA microarray results, real-time RT-PCR analysis was carried out to measure the 
abundance of CARD18 mRNA (Fig. 1.) using original RNA samples derived from 
organotypic skin cultures (healthy epidermis, n=5, and psoriatic non-involved epidermis, 
n=5). Our results confirmed the cDNA microarray results: we observed a 2-fold elevation of 
CARD18 mRNA level in psoriatic non-involved epidermis compared to healthy epidermis. 
Although the basal expression levels were relatively high in the psoriatic non-involved 
epidermis, it was not further induced in response to T-cell lymphokines. This was in contrast 
to the findings for healthy skin, where lower basal expression levels were induced with an 
average 1.65-fold elevation in response to the same treatment. 
 
3.2. CARD18 expression differs in healthy and diseased skin 
Using an organotypic skin model, we determined that CARD18 mRNA abundance was higher 
in psoriatic non-involved epidermis compared to healthy epidermis. To compare CARD18 
protein levels in healthy and diseased skin, immunohistochemical (IHC) staining was 
performed on paraffin-embedded samples from healthy (Fig. 2A), psoriatic non-involved (Fig. 
2B) and psoriatic involved skin samples (Fig. 2C) in an independent experiment. In all 
examined sections, CARD18 appeared exclusively in the epidermis, specifically in the 
cytoplasm of the epidermal keratinocytes. IHC revealed differential CARD18 expression in 
different skin samples: elevated levels were observed in the psoriatic-involved and non-
involved epidermis compared to the healthy epidermis (Fig 2B and 2C vs 2A). These results 
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confirmed our real-time RT-PCR findings. No differences were detected in the different 
keratinocyte layers of the epidermis; however, the level of CARD18 staining was somewhat 
higher in the suprabasal layers of psoriatic non-involved and involved epidermis. Figure 2D-F 
provide the data from negative controls for Figure 2A-C. 
 
3.3. CARD18 expression is differentially induced in healthy, psoriatic non-involved and 
psoriatic involved epidermis after tape stripping (TS) 
Mechanical stress causing disruption of the skin barrier leads to molecular responses, 
including a rapid increase in DNA synthesis and early over-expression of pro-inflammatory 
cytokines (Marionnet et al., 2003; Wood et al., 1997). It has long been known that baseline 
proliferative activity of keratinocytes of non-involved skin of psoriatic patients does not differ 
from keratinocytes in skin of healthy individuals; however, the proliferative response to TS or 
other trauma is significantly higher in psoriatic non-involved skin compared to healthy skin 
(Hatta et al., 1997; van de Kerkhof et al., 1983; Wiley and Weinstein, 1979). CARD18 protein 
expression was observed in mechanically stimulated skin from healthy and non-involved skin 
of psoriatic donors. Punch biopsies were taken before the procedure and two times after TS 
(24 and 48 hours). Compared to untreated sections (Fig. 3A, D, G), CARD18 protein 
expression level was induced 24 hours after TS in healthy (Fig. 3B), psoriatic non-involved 
(Fig. 3E) and psoriatic involved (Fig. 3H) samples, as well. However, the elevation of 
CARD18 expression in treated and untreated psoriatic non-involved samples was not as 
robust as in healthy or psoriatic involved skin. Forty-eight hours after the treatment, CARD18 
expression remained elevated only in the psoriatic non-involved samples (Fig. 3F). Negative-
control staining of the TS experiment is provided in the supplementary data (Supplementary 
Fig. 2.). 
 
3.4. CARD18 is abundantly expressed in differentiating keratinocytes 
To examine the characteristics of CARD18 in NHEKs, which are non-professional immune 
cells, we examined mRNA and protein changes in spontaneously differentiating NHEKs. In 
spontaneously differentiating third-passage NHEKs, the differentiation process was detected 
as an increase in a differentiation marker, keratin 10, and the decrease in a proliferation-
related marker, alpha5 integrin (data not shown). The 0-day samples were taken from 
subconfluent cultures. To determine the mRNA expression of CARD18, real-time RT-PCR 
was carried out using gene-specific primers. The in vitro gene-expression study revealed low-
level CARD18 mRNA expression in the proliferative state of cells, and this expression 
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continuously increased during differentiation: up to 43.2-fold elevation in the 10-day samples 
(Fig. 4A). 
To examine the expression of CARD18 protein, immunofluorescence staining was applied to 
keratinocytes, revealing that moderate positive CARD18 protein expression in samples taken 
on days 0–4 gradually increased in the 6–10-day samples (Fig. 4B). Thus, CARD18 protein 
expression followed a similar pattern observed for the mRNA expression during the 10-day 
course. The immunocytochemistry staining allowed the intracellular distribution to be 
determined and revealed that CARD18 was located in the cytoplasm of NHEKs, as it was 
observed in the epidermal keratinocytes of the ex vivo samples. 
 
3.5. CARD18 modifies the expression of molecules involved in cytosolic DNA-triggered 
responses of NHEKs 
To elucidate the cellular processes in which CARD18 participates and to gain further insight 
into its role in the pathomechanism of psoriasis, we investigated CARD18 expression in 
response to certain psoriasis-associated signals. Keratinocytes, as important immune-
competent cells, are able to sense danger signals and mediate immune response through the 
activation of pro-inflammatory signaling pathways (Nestle et al., 2009 b), resulting in the 
expression of inflammasome components and secretion of pro-inflammatory cytokines 
(Feldmeyer et al., 2007). 
Cytosolic DNA has been identified recently as a trigger for AIM2 inflammasome activation 
and is abundant in psoriatic-involved epidermis (Chiliveru et al., 2014; Dombrowski et al., 
2011). To mimic the effect of cytosolic DNA, a synthetic dsDNA analogue poly(dA:dT) was 
transfected into cultured keratinocytes. A significant increase in IL-1β release — up to 50 
pg/ml (Supplementary Fig. 3A) — as well as 3–5 fold increase in caspase-1 expression 
(Supplementary Fig. 3C) and a 200-fold increase in AIM2 expression (Supplementary Fig. 
3D) were observed, although changes in CARD18 mRNA were not detected (Supplementary 
Fig. 3B). 
To provoke enhanced inflammation, IFN-γ and TNF-α pre-treatment was performed before 
poly(dA:dT) transfection. IFN-γ is known to induce AIM2 gene expression (Lee et al., 2012), 
whereas TNF-α mediates pro-IL-1β transcription (Mills and Dunne, 2009), and both cytokines 
are consistently elevated in psoriatic skin. The co-treatment with IFN-γ, TNF-α and 
poly(dA:dT) resulted in increased IL-1β secretion — up to 100 pg/ml (Fig. 5A) — and 
increased the expression of caspase-1 and AIM2 mRNAs by 13-fold (Fig. 5C) and 250-fold 
(Fig. 5D), respectively. CARD18 mRNA level was also increased by six fold (Fig. 5B).  
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These results encouraged us to further characterize the function of CARD18 in keratinocytes 
in which inflammatory processes had been induced. CARD18 expression was silenced by 
siRNA 24 hours before IFN-γ and TNF-α treatment and the subsequent poly(dA:dT) 
transfection. The applied siRNA effectively down-regulated CARD18 expression to 50% of 
the levels observed for the scrambled control cells (Fig. 6B).  
The CARD18 silencing resulted in a significant decrease in AIM2 gene expression 12 and 24 
hours after treatment (Fig. 6C) and significantly reduced caspase-1 mRNA expression (Fig. 
6D) 24 hours after the treatment. For further confirmation, we determined whether the 
silencing of CARD18 had any effect on IL-1β secretion: our results indicated that 
downregulation of CARD18 expression affected an elevation of IL-1β production in 
keratinocytes (Fig. 6A). These results indicate that CARD18 might indeed contribute to the 
fine-tuning of inflammatory processes in keratinocytes and suggest that — similar to the role 
in professional immune cells (Humke et al., 2000) — functions as a negative regulator of 
inflammasome activation in keratinocytes. 
 
4. Discussion 
 
IL-1β is an important mediator in the in the induction and maintenance of psoriasis (Bernard 
et al., 2012; Feldmeyer et al., 2010) and represents a potential therapeutic target; therefore, 
several studies have targeted possible inhibitors of IL-1β (Mansouri et al., 2015; Tamilselvi et 
al., 2013; Yun et al., 2015). IL-1β and IL-18 are generated by a number of different 
inflammasomes in response to various environmental influences and this process is likely 
further modulated by additional genetic factors (Masters, 2013). The importance of these 
multi-protein platforms has been reported in several inflammatory diseases, including 
psoriasis (Dombrowski et al., 2011; Mason et al., 2011). Specific inflammasome inhibitors 
rectify the balance between beneficial and deleterious IL-1β and IL-18 production. CARD18 
has been identified as a negative regulator of inflammasome activation through direct 
interaction with the CARD domain of pro-caspase-1 and abrogation of IL-1β and Il-18 
production in macrophages (Humke et al., 2000). We have identified CARD18 as a highly 
expressed transcript in psoriatic non-involved epidermis and demonstrated its abnormal 
regulation in psoriatic non-involved epidermis (Szabó et al., 2014). To understand the 
pathologic functions of CARD18 in skin inflammation, we studied CARD18 under normal 
and inflammatory conditions both in vitro and in vivo. 
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In organotypic skin cultures, CARD18 mRNA basal expression level was higher in psoriatic 
non-involved epidermis than healthy epidermis. In addition, samples of different origin 
exhibited different responses to lymphokine induction. The higher basal expression of 
CARD18 mRNA in psoriatic non-involved samples was not further increased following T-cell 
lymphokine treatment. In contrast, healthy epidermis exhibited lower CARD18 mRNA basal 
expression, which was induced by the cytokine treatment.  
In human skin, CARD18 protein and mRNA exhibited similar accumulation patterns: 
histological staining showed higher CARD18 expression in non-involved and involved 
epidermis than in healthy epidermis. Mild injury (i.e., TS) induced CARD18 protein 
expression in all examined skin samples. However, the level of induction was different: 
modest elevation was detected in psoriatic non-involved epidermis compared to healthy and 
psoriatic involved epidermis. The higher basal level and the lack of response of CARD18 
gene and protein expression in psoriatic non-involved epidermis might indicate a “ceiling 
effect” or impaired regulation of inflammatory signaling, similar to the phenomenon that has 
been described for IL-1β production in keratinocytes and in salivary glands (Mastrolonardo et 
al., 2007; Szabó et al., 2014). 
Although keratinocytes are able to express inflammasome components and secrete IL-1β, we 
observed very low — sometimes undetectable — levels of AIM2, caspase-1 and CARD18 
mRNA and IL-1β secretion in uninduced keratinocytes. Compared to the untreated cells, 
however, treatment with a combination of inflammation-related stress factors significantly 
increased both the expression of inflammasome components and IL-1β secretion. The applied 
triggering factors, such as IFN-γ and TNF-α priming followed by poly(dA:dT) transfection 
are also known to contribute to the pathogenesis of psoriasis (Dombrowski et al., 2011; Nestle 
et al., 2009 a). 
To gain some information about the function of CARD18 in keratinocytes under 
inflammatory conditions, we silenced CARD18 expression. CARD18 silencing resulted in a 
modest but significant elevation of IL-1β secretion in poly(dA:dT)-treated cells, suggesting 
that, similar to professional immune cells, CARD18 indeed has a negative regulatory role in 
keratinocyte innate immune functions. Interestingly, reduced inflammasome activation was 
detected as decreased AIM2 and caspase-1 gene expression in the CARD18 silenced cells. 
We hypothesize that IL-1β secretion is a highly regulated process both in professional and in 
non-professional immune cells, such as keratinocytes. Thus, the silencing of CARD18 might 
up- and down-regulate multiple process simultaneously, resulting in only a mild change in IL-
1β secretion. The reduced inflammasome activation data suggest the present of a negative 
13 
 
feedback loop: elevated active caspase-1 down-regulates caspase-1 and AIM2 gene 
expression through a yet unknown control mechanism. Juruj et al has recently published 
results supporting this hypothesis: the authors demonstrated that caspase-1 negatively 
regulated the formation or stability of the AIM2 inflammasome complex, and that this 
regulation was specific to the AIM2 inflammasome pathway in macrophages (Juruj et al., 
2013). 
Nair and coworkers demonstrated that caspase-1, AIM2 and IL-1β mRNAs are present at low 
levels in healthy and non-involved skin, and that the expression of these molecules increases 
significantly in psoriatic involved skin (Nair et al., 2009). Moreover, caspase-1 protein 
expression is increased in involved psoriatic skin compared to non-involved psoriatic skin, 
whereas procaspase-1 expression is unchanged. Under normal conditions, caspase-1 activity 
has not been detected in the skin (Johansen et al., 2007). During inflammation, AIM2 
inflammasome (De Koning et al., 2012) and caspase-1 become activated both in professional 
immune cells and keratinocytes and induce the abnormal inflammatory responses observed in 
inflammatory skin diseases. The regulation of caspase-1 is undoubtedly an important 
checkpoint in IL-1β production and, thus, in the pathogenesis of chronic inflammatory skin 
diseases, such as psoriasis. By performing a set of in vitro experiments in this study, we have 
demonstrated that CARD18, an endogenous decoy protein proposed to interfere with caspase-
1 activation, is part of the inflammasome regulatory processes that has been previously 
described (Dombrowski et al., 2011; Johansen et al., 2007). Moreover, our primary expression 
experiments clearly showed that CARD18 exhibits aberrant expression and inductivity in 
psoriatic epidermis. Although knowledge of CARD18 and other COP family members is 
limited, these small proteins could be promising targets for treating inflammatory diseases. 
Our findings regarding misregulated CARD18 expression in psoriasis suggest that this 
molecule may contribute to disease pathogenesis and could be a potential target for therapy. 
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Figures 
 
 
 
 
Figure 1. CARD18 gene expression in healthy and non-involved psoriatic epidermis. 
Total RNA was isolated from the epidermal compartment of organotypic skin cultures (n=5). 
CARD18 gene expression patterns in response to T-cell lymphokine (GM-CSF, IL-3, IFN-ɣ) 
treatment in healthy epidermis and in non-involved psoriatic epidermis. Horizontal lines 
represent mean values.* P>0.05 
 
  
19 
 
 
 
 
 
Figure 2. Immunohistochemical staining of CARD18 in healthy and psoriatic skin. 
CARD18 protein levels were analyzed in healthy (A), psoriatic non-involved (B), and 
psoriatic involved (C) skin. Negative controls were performed for healthy (D), psoriatic non-
involved (E) and psoriatic involved skin (F). Bar = 100 μm. 
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Figure 3. CARD18 expression upon acute barrier disruption. Tape stripping (TS) method 
was carried out on the skin of healthy (n=2, one representative picture is shown) and psoriatic 
volunteers (n=2, one representative picture is shown). Punch biopsies were taken at the 
indicated time points. Skin samples were subjected to immunohistochemical staining of 
CARD18: healthy untreated (A), healthy TS at 24 h (B), healthy TS at 48 h (C), psoriatic non-
involved untreated (D), psoriatic non-involved TS at 24 h (E), psoriatic non-involved TS at 48 
h (F), psoriatic involved untreated (G), psoriatic involved TS at 24 h (H), psoriatic involved 
TS at 48 h (I). Bar = 100 μm. 
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Figure 4. Expression of CARD18 mRNA and protein during keratinocyte proliferation 
and differentiation. Cultured NHEKs (n=3) were grown to subconfluency before samples 
were taken (0 day). (A) Changes in CARD18 mRNA expression were analyzed by real-time 
RT-PCR at the indicated time points. Relative expression is shown compared to the 0-day 
sample. (B) CARD18 intracellular protein localization was detected in NHEKs (n=3, one 
representative picture is shown) at the indicated time points. Samples were fixed and 
immunostained for CARD18 (red). DAPI was used for nuclear counterstaining. 
Magnification: 20X. 
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Figure 5. The response of cytokine-primed keratinocytes to synthetic DNA analogue 
(poly(dA:dT)) transfection. NHEK cultures (n=3) were incubated with IFN-ɣ and TNF-α for 
24 hours, followed by poly(dA:dT) transfection. Samples were taken at the indicated time 
points. IL-1β secretion (A) was measured by ELISA method. CARD18 (B), caspase-1 (C) and 
AIM2 (D) mRNA expression was determined by real-time RT-PCR. Relative expressions are 
shown compared to the 0 hour sample. * P>0.05 
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Figure 6. The effect of CARD18 gene-specific silencing in cytokine-primed poly(dA:dT) 
transfected NHEKs. CARD18 expression was silenced in NHEK cultures (n=3). CARD18 
siRNA, scrambled control and mock-transfected cells were subsequently treated with a 
mixture of IFN-ɣ and TNF-α (12 hours) and transfected with poly(dA:dT). Samples were 
taken at the indicated times. IL-1β secretion (A) was measured by ELISA. CARD18 (B), 
caspase-1 (C) and AIM2 (D) mRNA expression was analyzed by real-time RT-PCR. 
Expression is relative to the 0 hour sample, except for AIM2, where arbitrary units were used. 
* P>0.05 
